2022 ICD-10-CM Code D03.122

Melanoma in situ of left lower eyelid, including canthus

Version 2021

Valid for Submission

ICD-10:D03.122
Short Description:Melanoma in situ of left lower eyelid, including canthus
Long Description:Melanoma in situ of left lower eyelid, including canthus

Code Classification

D03.122 is a billable diagnosis code used to specify a medical diagnosis of melanoma in situ of left lower eyelid, including canthus. The code D03.122 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.

Replacement Code

D03122 replaces the following previously assigned ICD-10 code(s):

Information for Patients


Melanoma

Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color, or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal, or "ugly looking."

Thinking of "ABCDE" can help you remember what to watch for:

Surgery is the first treatment of all stages of melanoma. Other treatments include chemotherapy and radiation, biologic, and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Melanoma Summary Learn about melanoma risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019